专题:Metabolism, Diabetes, and Cancer

This cluster of papers explores the role of AMP-activated protein kinase (AMPK) in regulating cellular metabolism, including its involvement in glucose and lipid metabolism, insulin signaling, mitochondrial homeostasis, and the potential impact on cancer risk. The cluster also delves into the mechanisms of action of metformin, a drug known to activate AMPK and its effects on cellular energy balance and gene expression regulation.
最新文献
Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study

article Full Text OpenAlex

Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial

article Full Text OpenAlex

Lactate metabolism and lactylation in cancer: from pathogenesis to therapeutic advances

article Full Text OpenAlex

Acalypha Indica Attenuates Insulin Resistance In Stz-Induced Type 2 Diabetic Male Rats: Mechanistic Study

article Full Text OpenAlex

Survival and Recurrence With GLP-1 Receptor Agonists in Breast Cancer

article Full Text OpenAlex

Metformin inhibits mitochondrial complex I in intestinal epithelium to promote glycaemic control

article Full Text OpenAlex

GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis

review Full Text OpenAlex

Concept and connotation of the geroprotective and anti-aging effects of metformin: From AMPK activation to SASP suppression

article Full Text OpenAlex

GLP-1 Receptor Agonists

article Full Text OpenAlex

The association between GLP-1 receptor agonists and fractures: a nationwide Danish nested case-control study

article Full Text OpenAlex

近5年高被引文献
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

article Full Text OpenAlex 2836 FWCI421.2467

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes

article Full Text OpenAlex 1666 FWCI430.9726

The hallmarks of cancer metabolism: Still emerging

article Full Text OpenAlex 1418 FWCI103.2113

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

article Full Text OpenAlex 1028 FWCI106.6958

Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

review Full Text OpenAlex 1001 FWCI54.0348

New insights into activation and function of the AMPK

article Full Text OpenAlex 995 FWCI61.9188

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension

article Full Text OpenAlex 994 FWCI90.8983

Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease

article Full Text OpenAlex 909 FWCI83.8562

Glucagon-like peptide-1 receptor: mechanisms and advances in therapy

article Full Text OpenAlex 901 FWCI233.077

Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

article Full Text OpenAlex 822 FWCI80.8681